Morphogenesis-regulated localization of protein kinase A to genomic sites in Candida albicans
DOI: 10.1186/1471-2164-14-842
© Schaekel et al.; licensee BioMed Central Ltd. 2013
Received: 3 June 2013
Accepted: 15 November 2013
Published: 1 December 2013
Abstract
Background
The human fungal pathogen Candida albicans is able to undergo morphogenesis from a yeast to a hyphal growth form. Protein kinase A (PKA) isoforms Tpk1 and Tpk2 promote hyphal growth in a signalling pathway via the transcription factor Efg1.
Results
C. albicans strains producing epitope-tagged Tpk1 or Tpk2 were used in genome-wide chromatin immunoprecipitation on chip (ChIP chip) to reveal genomic binding sites. During yeast growth, both PKA isoforms were situated primarily within ORFs but moved to promoter regions shortly after hyphal induction. Binding sequences for Tpk2 greatly exceeded Tpk1 sites and did not coincide with binding of the PKA regulatory subunit Bcy1. Consensus binding sequences for Tpk2 within ORFs included ACCAC and CAGCA motifs that appeared to bias codon usage within the binding regions. Promoter residency of Tpk2 correlated with the transcript level of the corresponding gene during hyphal morphogenesis and occurred near Efg1 binding sites, mainly on genes encoding regulators of morphogenesis.
Conclusions
PKA isoforms change their genomic binding sites from ORF to promoter regions during yeast-hyphal morphogenesis. Tpk2 binds preferentially to promoters of genes encoding regulators of cellular morphogenesis.
Keywords
Candida albicans Protein kinase A Tpk1 Tpk2 Efg1 MorphogenesisBackground
The fungus Candida albicans is an important cause of human disease, causing tenacious superficial and life-threatening systemic infections. Its virulence depends to a large extent on its ability to switch between a yeast and a hyphal growth form [1]. Environmental conditions favouring hyphal development include molecules of the human host acting as inducers, as well as physical parameters such as body temperature. Protein kinase A (PKA) isoforms Tpk1 and Tpk2 have crucial roles as signalling kinases because they mediate several adaptation responses to host contact [2–4]. In inducing conditions, cAMP is generated by adenylate cyclase (Cyr1) and triggers PKA activity by binding and removal of the inhibitory subunit Bcy1, which associates with Tpk1 and Tpk2 [5–7]. The cAMP-PKA pathway subsequently activates the Efg1 transcription factor, which represents the central hub controlling downstream events including morphogenesis and metabolic adaptation [1, 8–10]. Efg1 fulfills its morphogenetic functions by association with co-regulators Czf1, Flo8, Slf1 and Slf2 [11, 12]. Interestingly, in spite of their association with the same regulator protein Bcy1, both PKA isoforms exert specific environment-dependent functions with regard to hyphal morphogenesis [3] and Tpk2 but not the Tpk1 isoform mediates downregulation of EFG1 expression early in hyphal induction [13].
PKA localization differs among species: in budding yeast the PKA holoenzyme is localized in the nucleus [14], whereas in fission yeast it resides in the cytoplasm [15] and in mammalian cells PKA catalytic subunits bind to anchoring proteins in different intracellular localizations [16, 17]. In spite of these differences, it appears that in all species important AGC kinase activities are needed in the nucleus. Increased cAMP levels lead to partial entry of PKA catalytic subunits into nuclei of fission yeast [15] and mammalian cells [16, 17]. In C. albicans, phosphorylation of the Tpk2 target protein Efg1 is likely to occur in the nucleus since Efg1 has been detected exclusively in the nucleus [18]. In Saccharomyces cerevisiae, activated PKA and the mitogen-activated protein kinase (MAPK) Hog1 were found to associate with promoters and coding regions of genes regulated by these kinases [19–21]. Action of the Hog1 MAPK on the Sko1 trancriptional repressor required the activity of kinase Sch9, which is structurally related to PKA, on the promoters of target genes [22]. The latter findings suggested that also in C. albicans, Tpk isoforms and possibly other kinases reside on genes that represent downstream targets of PKA signalling during hyphal morphogenesis. In this study, we strengthen this concept by demonstrating that PKA isoforms reside on specific genomic locations that change dramatically during morphogenesis from ORF to promoter regions. During the yeast-hyphal transition, genomic Tpk2 binding sites identify genes with known functions in dimorphism and suggest the identity of new genes involved in this cellular differentiation process.
Results and discussion
C. albicansstrains producing HA-tagged PKA kinases
Epitope-tagged PKA in C. albicans. A. Immunoblotting to detect HA-tagged PKA subunits. Strains were grown in liquid YPD medium to OD600 = 0.6-0.8 and proteins in cell extracts (50 μg) were separated by SDS-PAGE (10% acrylamide), blotted onto PVDF membranes and probed using anti-HA antibody. Strains tested were CAF2-1 (WT: lanes 1, 5), AF1003 (TPK1 HA : lane 2), AF1004 (TPK1 HA : lane 3), AF1005 (TPK2 HA : lane 4) and AF1007 (BCY1 HA : lane 6). B. Fluorescence microscopy of transformant cells treated with rat anti-HA antibody, which was detected with FITC-labelled anti-rat antibody (green signal) and DAPI to detect nuclei (red signal); yellow overlay signals are indicated by white triangles. C. Filament formation of strains producing HA-tagged Tpk proteins. Strains CAF2-1 (wt), II (TPK1/tpk1), TPK7 (TPK2/tpk2), TPO7.4 (tpk2/tpk2), AF1003 (TPK1 HA /TPK1), AF1004 (TPK1 HA /tpk1) and AF1005 (TPK2 HA /tpk2) were grown for 3 d/37°C on Spider agar and single colonies were photographed.
To verify that HA fusion proteins were functional in the constructed strains we tested their filamentous growth, which is known to be regulated by the activity of Tpk1 and Tpk2 proteins [2, 3]. Inactivation of a single TPK1 allele abolishes hyphal growth [3] but the TPK1 HA /TPK1 transformant formed hyphae as the wild-type strain (Figure 1C) indicating that the Tpk1HA fusion protein is functional. Both TPK2 alleles need to be inactivated to prevent hyphal growth [2]; therefore, it was verified that the filamentation phenotype of the TPK2 HA /tpk2 strain mimicked the TPK2/tpk2 strain but not the tpk2/tpk2 homozygous mutant (Figure 1C). This result shows that the Tpk2HA fusion protein is functional. In summary, use of HA-tagged Tpk proteins revealed that in C. albicans as in fission yeast [15] the majority of PKA is located in the cytoplasm. The exclusive localization of a possibly non-functional Tpk1-GFP fusion within the nucleus [5] was not confirmed by the HA-tagged Tpk1 protein.
Genomic localization of Tpk proteins
The above results suggested that a minor fraction of cellular PKA catalytic subunits resides in the nucleus of C. albicans cells. Furthermore, the presence of PKA isoforms and other kinases at target genes had been demonstrated previously in S. cerevisiae[19–21]. To verify, if nuclear PKA isoforms bind specific genomic targets in C. albicans we performed ChIP chip experiments with strains containing HA-tagged PKA isoforms; strains producing authentic non-tagged Tpk proteins were used as reference strains. Tpk1 and Tpk2 localization was examined during yeast growth or alternatively, following a brief period (30 min) of hyphal induction by 10% serum. During this time period, early regulatory processes take place that reprogram cells to allow hyphal growth. This became evident in wild-type cells by the formation of germ tubes after 30–60 min of induction.
Genomic localization of PKA subunits. A. Genomic binding of PKA subunits. Venn diagrams number genes containing Tpk1 or Tpk2 binding sites in their promoter or ORF sequences; cells were grown in the yeast form or induced 30 min for hypha formation using 10% horse serum. Names of genes in the Tpk1/Tpk2 intersection are listed. B. Genomic PKA subunit localization. For each subunit, numbers of binding sites inside an ORF (black box), outside an ORF (promoter) (grey box) or at both sites (white box) are listed. C. Genomic binding of Tpk1, Tpk2 and Bcy1 subunits. The Venn diagram numbers indicate genes associated with the Tpk1 or Tpk2 catalytic subunit under yeast growth or hyphal induction, as well as the localization of the Bcy1 regulatory subunit during yeast growth. Gene names in the intersections are indicated.
Importantly, during yeast growth both Tpk1 and Tpk2 were bound mostly within ORFs of target genes, while hyphal induction reduced ORF binding and favoured promoter binding or joint promoter-ORF binding (Figure 2B). Under yeast and hyphal growth conditions, all Tpk1 target genes and the majority of Tpk2 target genes were different (Figure 2C). Thus, ORF-to-promoter switching rarely occurs on the same gene during yeast-hyphal morphogenesis.
Growth of C. albicans in rich medium does not trigger hyphal formation, because PKA activity is repressed by the regulatory PKA subunit Bcy1 [5]. To test if during yeast growth both Tpk isoforms and Bcy1 bind to ORFs a ChIP chip experiment was performed on a BCY1 HA /BCY1 strain (AF1007). Immunoblotting showed the production of HA-tagged Bcy1 in transformants (Figure 1A) and immunofluorescence demonstrated that this protein resides mainly in the cytoplasm (Figure 1B). The Bcy1HA fusion produced by transformants is functional because the BCY1 HA /BCY1 strain was insensitive to heat shock (2 h at 50°C) (data not shown), unlike a BCY1/bcy1 strain [4]. Data analyses revealed a moderate number of genomic Bcy1 binding sites during yeast growth (see Additional file 1: Table S5). However, binding sites did not coincide to a great extent with Tpk1 or Tpk2 binding sites, either during yeast growth or during hyphal induction (Figure 2C). These results indicate that in general, Tpk1 or Tpk2 isoforms do not bind to target ORFs in the form of Tpk-Bcy1 holoenzyme complexes. Conceptually, ORF-bound Tpk proteins could either be active because of the absence of Bcy1 or their activities may be regulated by yet unknown mechanisms.
Gene ontology analysis of PKA binding sites
GO terms of genes associated with Tpk2 binding sites. A. Tpk2 binding sites during yeast growth. B. Tpk2 binding sites during hyphal induction. GO terms for Tpk2 binding targets were identified in ChIP chip data using the CGD GO Term Finder tool (http://www.candidagenome.org/cgi-bin/GO/goTermFinder). 1Genomic frequencies of genes corresponding to specific GO terms are expressed as percentages (gene number relative to 6,525 genes in the C. albicans genome [24]. Analysis conducted in April 2013. 2Gene name or ORF19 nomenclature according to CGD [24]. Some genes were attributed to more than one GO term. Red lettering: Tpk2 binding in ORF; blue lettering: Tpk2 binding in promoter and ORF; black lettering: Tpk2 binding in promoter a, b, cEfg1 binds to promoter regions in ayeast growth, bhyphal induction or cbiofilm induction [13, 25, 26]. d, eSet3 binding in dyeast or ehyphae inducing conditions [27]. 3Percentages were calculated based on the number of genes in each GO category divided by the total number (196 genes for Tpk2 in yeast form and 218 genes for Tpk2 in hyphal inducing conditions). 4P values for overrepresented categories were calculated using a hyper geometric distribution with multiple hypothesis correction according to the GO Term Finder tool website (http://www.candidagenome.org/help/goTermFinder.shtml). The P value cutoff used was 0.1. *Genes upregulated during hyphal induction [24, 28].
ORF binding during yeast growth
ORF binding by PKA isoforms occurred mainly during yeast growth and included two relevant C. albicans genes, EFG1 and MSB2. EFG1 is required for the initial phase of yeast-hyphal transition but it is downregulated rapidly by negative autoregulation to allow undisturbed morphogenesis [29]; downregulation requires the Tpk2 but not the Tpk1 PKA isoform [13]. MSB2 encodes a membrane sensor for environmental cues leading to hypha formation via the Cek1 MAPK and its shed domain provides resistance to antimicrobial peptides [30, 31].
Tpk binding to EFG1 and MSB2 loci. A. Binding to EFG1. Coordinates of EFG1 and neighbouring genes on chromosome R are shown on top. Round circles (dotted lines) indicate the position of Efg1 binding during growth in the yeast form [13]; the kinked arrow indicates the transcript start site. The genomic localization of Tpk1 and Tpk2 was determined by ChIP chip assays on strains containing HA-tagged Tpk proteins relative to an unmarked control strain. For Tpk1 localization, the strain pair II (TPK1/tpk1)/AF1004 (TPK1-3× HA/tpk1) and for Tpk2 localization, the strain pair TPK7 (TPK2/tpk2)/AF1005 (TPK2-3× HA/tpk2) was used in ChIP chip. Graphs represent duplicates of TpkHA occupancy at the EFG1 locus, ordinates represent scaled log2 ratios. B. Binding to MSB2. Tpk2 enrichment in (a) the MSB2 ORF of yeast cells or (b) in the MSB2/ORF19.1488 upstream region of cells following hyphal induction; the most significant binding sequences are indicated by the dotted box. Transcript levels of MSB2 (c) or ORF19.1488 (d) in yeast or in induced cells were determined by qPCR in wild-type CAF2-1 (TPK2) or in tpk2Δ mutant cells (strain TPO7.4) growing in the yeast form or induced 30 min for hypha formation. Transcript levels relative to the ACT1 transcript (RTL) are shown for two biological replicates (black and grey bars) indicating means and standard deviations for three technical replicates.
Promoter binding during hyphal induction
During hyphal induction PKA isoforms bound preferentially to promoter regions. At the EFG1 promoter extensive binding of Tpk1 but not of Tpk2 was detected (Figure 4A). The broad Tpk1 binding area ranges from the EFG1 transcriptional start site through 1169 bp untranslated upstream sequences and ends close to the 3′end of the EFG1 ORF. The Tpk1 binding area matches one of the major binding sites for Efg1 in the yeast form indicating that shortly after hyphal induction, Tpk1 binding occurs concomitant with the release of Efg1 [13]. EFG1 promoter downregulation had been also observed in a tpk1 mutant [13] suggesting that Tpk1 has no major role in negative autoregulation of EFG1.
Tpk2 promoter binding during hyphal induction. Tpk2 localization was determined in cells induced for hypha formation at SOK1 (A), HYR1 (B) and ECE1 (C) genomic loci. ChIP chip occupancy values of Tpk2HA were determined in duplicates as in Figure 4; peak binding areas are marked by a dotted box. All three genes contain Efg1 binding sites within their promoters (circles) at the indicated coordinates; positions marked were reported by Nobile et al.[25] and by Lu et al.[26] (asterisks). The kinked arrow indicates the SOK1 transcript start site [24]. Transcript levels for each gene during yeast growth or hyphal induction were determined by qPCR as in Figure 4B.
Promoter regions of SOK1, HYR1 and ECE1 genes are known to bind the Efg1 regulator relatively late during hyphal induction [26] or during biofilm formation [25], while no Efg1 binding was detected shortly (30 min) after hyphal induction [13]. Interestingly, Efg1 binding sequences are not identical but overlap partially with the sequences bound by Tpk2 (Figure 5A-C). Taken together, these results suggest that Tpk2 binding to promoters has the potential to regulate transcription of C. albicans genes both negatively and positively, possibly involving subsequent binding of Efg1 as a PKA phosphorylation target [9].
Sequence motifs in Tpk2 binding regions
Tpk2 binding specificity. A. Consensus sequences for Tpk2 binding sites in yeast cells (left) or in cells induced for hypha formation (right). The program RSAT dyad-analysis [36] was used to predict consensus sequences. Predicted dyads (pairs of trinucleotides) common to Tpk2 binding sites were ranked and qualified by their P-/E-values; the frequencies of the deduced consensus sequences and of closely related sequences relative to all binding sites are listed below each table. B. Occurrence of trinucleotides/codons in ORF regions bound by Tpk2 during yeast growth. Codons corresponding to the Tpk2 binding consensus sequence are listed, along with codon frequencies in all C. albicans ORFs, in a randomly picked group of 150 genes not binding Tpk2 (out group) and in the 204 Tpk2 binding regions occurring mostly within ORFs.
Binding of Tpk2 to many ORFs raised the question if such bound ORF sequences were as free as unbound regions to evolve sequence variants, e. g. with regard to the usage of synonymous codons. Therefore, we compared overall C. albicans codon usage with codon usage in ORF sequences bound by Tpk2. Specifically, we investigated if codons corresponding to the deduced Tpk2 binding consensus sequences would be preferred in the Tpk2 binding region. It was indeed found that usage of all six codons matching the Tpk2 consensus sequence during yeast growth was increased as compared to the average codon usage in C. albicans or to random set of 150 ORFs (“out group”) that are not bound by Tpk2 (Figure 6B). In the case of histidine even a complete reversal of codon usage from the preferred CAT codon (15.62/1000 to 8.63/1000) to CAC (5.39/1000 to 11.4/1000) was observed in the Tpk2 binding region. This result suggests that ORF binding Tpk2 has a vital, yet unknown function, because it exerts selective pressure to restrict codon usage within ORFs. Codon usage has hitherto been related mainly to abundance of aminacyl-tRNAs [40].
PKA localization at the EFG1locus
Residency of PKA isoforms at the EFG1 locus during hyphal induction. During yeast growth, Efg1 [13] and Tpk2 proteins reside on promoter and ORF, respectively, and EFG1 is transcribed at high levels (top). During initiation of hyphal formation, increased cAMP levels activate Tpk isoforms by removing Bcy1 repression and Tpk2 phosphorylates Efg1 [9]. This is followed by rapid removal of both Efg1 [13] and Tpk2 (indicated by open arrows). Subsequently the Tpk1 isoform enters the EFG1 promoter at one of the previous Efg1 binding sequences and the Set3C histone deacetylase [27] occupies the ORF. Other proteins including Czf1, Sfl1, Sfl2 and Ndt80 are known to bind the EFG1 promoter [12, 25] and may contribute to Tpk-dependent regulation of EFG1 expression.
Conclusions
PKA isoforms Tpk1 and Tpk2 are crucial for the virulence of the human fungal pathogen C. albicans by regulating dimorphic growth. Tpk proteins mediate environmental cues and trigger hyphal morphogenesis by altering the transcriptional program. We show that Tpk2 and to a lesser extent Tpk1 bind to specific genomic sequences within ORFs and promoters of target genes. Growth in the yeast form triggers Tpk binding to CA-rich sequences within ORFs and appears to bias codon usage within the binding region. During hyphal induction Tpk2 associates with promoter regions of genes regulating or regulated by hyphal morphogenesis, often proximal to binding sites for the Efg1 transcription factor. These results suggest that genomic PKA proteins facilitate and/or prolong hyphal morphogenesis by acting on nearby transcription factors at genes regulating morphogenesis. Molecular mechanisms of PKA nuclear import, genomic recruitment and function remain to be established. In conclusion, we have demonstrated for the first time in a fungal pathogen that PKA isoforms, which are responsible for a relatively simple developmental program in a single cell, mark downstream target genes. Such binding analyses have predictive value because they link yet uncharacterized genes to signalling by PKA isoforms. This concept may hold true for other cellular differentiation processes involving other types of kinases and other species.
Methods
Strains and growth conditions
C. albicans strains
Strains | Reference | |
|---|---|---|
CAF2-1 | URA3/ura3::imm434 | [42] |
CAI4 | ura3::imm434/ura3::imm434 | [42] |
II | As CAI4 but TPK1/tpk1::hisG-URA3-hisG | [3] |
FII4a | As CAI4 but TPK1/tpk1::hisG | [3] |
AF1003 | As CAI4 but TPK1::(3xHA-URA3)/TPK1 | This work |
AF1004 | As FII4a but TPK1::(3xHA-URA3)/tpk1::hisG | This work |
TPK7 | As CAI4 but TPK2/tpk2::hisG-URA3-hisG | [2] |
TPO7 (AF1001) | As TPK7 but TPK2/tpk2::hisG | [2] |
TPO7.4 | As CAI4 but tpk2::hisG/tpk2::hisG-URA3-hisG | [2] |
AF1005 | As AF1001 but TPK2::(3xHA-URA3)/tpk2::hisG | This work |
AF1007 | As CAI4 but BCY1::(3xHA-URA3)/BCY1 | This work |
Immunodetection
Proteins containing a hemagglutinin (HA) antigenic tag were detected in cell extracts by immunoblotting using monoclonal rat anti-HA antibody (Roche; 1:1000), which was visualized on blots using peroxidase-coupled goat antibody (Pierce; 1:10000). Cells used for immunofluorescence microscopy were fixed by 4% formaldehyde and 1 ml of cell suspension were treated by zymolyase T100 (100 μg), glucuronidase (30 μl) and 10 mM DTT for 30 min at 30°C. Cells were pelleted and treated with 0.1% Triton X-100 for 5 min at room temperature. Cells (20 μl) were fixed to polylysine-coated glass slides and washed with PBS, followed by blocking of unspecific binding sites using 2% milk powder in PBS. The blocking solution was removed and 40 μl of rat anti-HA antibody (Roche; 1:100) were allowed to react 90 min at room temperature or overnight at 4°C in a wet chamber. Cells were washed and fluorescein isothiocyanate (FITC)-coupled goat anti-rat antibody (Jackson Immunologic Research Lab Inc.; 1:100) in 0.2% milk powder was added and allowed to react for 90 min at room temperature. For nuclear staining 20 μl diamidino-2-phenylindole (DAPI; 1 μg/ml) was added for 15 min at room temperature. Slides were washed by PBS and a drop of anti-fade (Pro-Long Anti-Fade, Sigma) was added before covering the specimen with a cover slip, which was sealed by nail polish. Microscopic inspection of FITC and DAPI fluorescence was done using a spinning disc confocal microscope (Cell Observer® SD; Yokogawa CSU-X1) and using the program Zen 2011 (Carl Zeiss) for evaluation of images.
Chromatin immunoprecipitation on microchips (ChIP chip)
The ChIP chip procedure was carried out essentially as described [13] except that magnetic beads with bound antibodies were eluted twice with elution buffer for 20 min at 65°C and that RNA was removed by adding 2.5 μl of RNase A (10 mg/ml; Qiagen). C. albicans genomic tiling microarrays were probed pairwise by immunoprecipitated chromatin of a strain producing an HA-tagged protein and a corresponding control strain. The following pairs of strains were used: II (TPK1/tpk1)/AF1004 (TPK1-3× HA/tpk1), TPK7 (TPK2/tpk2)/AF1005 (TPK2-3× HA/tpk2), CAF2-1 (BCY1/BCY1)/AF1007 (BCY1-3× HA/BCY1). Two independent cultures were assayed for each combination of strains. Significant binding peaks were defined as probes containing four or more signals above background in a 500 bp sliding window; the degree of significance depended on the FDR value. Results were visualized using the program SignalMap (version 1.9). The most significant binding peaks (FDR ≤ 0.05), which coincided in both replicates, were analyzed by the program RSAT dyad-analysis to predict binding sequence from all peak genomic binding sites [36]. Codon usage of all C. albicans genes was derived from the Candida Genome Database [24] and codon usage in sequences of ORFs bound by Tpk2 were calculated using the Codon Usage Calculator [43].
Availability of supporting data
The data sets supporting the results of this article are available in the Candida Genome Database (CGD) repository: http://www.candidagenome.org/download/systematic_results/Schaekel_2013/.
Declarations
Acknowledgements
We thank the members of the CAI center, Heinrich-Heine-Universität Düsseldorf, for assistance in microscopy. We thank K. Sanyal for helpful discussions. This project was supported by the Jürgen Manchot Stiftung Düsseldorf, by the Deutsche Forschungsgemeinschaft (ER47.13-1) and by ERA-NET PathoGenoMics project OXYstress.
Authors’ Affiliations
References
- Sudbery PE: Growth of Candida albicans hyphae. Nat Rev Microbiol. 2011, 9: 737-748. 10.1038/nrmicro2636.View ArticlePubMedGoogle Scholar
- Sonneborn A, Bockmühl DP, Gerads M, Kurpanek K, Sanglard D, Ernst JF: Protein kinase A encoded by TPK2 regulates dimorphism of the human pathogen Candida albicans. Mol Microbiol. 2000, 35: 386-396. 10.1046/j.1365-2958.2000.01705.x.View ArticlePubMedGoogle Scholar
- Bockmühl DP, Krishnamurthy S, Gerads M, Sonneborn A, Ernst JF: Distinct and redundant roles of the two protein kinase A isoforms Tpk1p and Tpk2p in morphogenesis and growth of Candida albicans. Mol Microbiol. 2001, 42: 1243-1257.View ArticlePubMedGoogle Scholar
- Giacometti R, Kronberg F, Biondi RM, Passeron S: Catalytic isoforms Tpk1 and Tpk2 of Candida albicans PKA have non-redundant roles in stress response and glycogen storage. Yeast. 2009, 26: 273-285.View ArticlePubMedGoogle Scholar
- Cassola A, Parrot M, Silberstein S, Magee BB, Passeron S, Giasson L, Cantore ML: Candida albicans lacking the gene encoding the regulatory subunit of protein kinase A displays a defect in hyphal formation and an altered localization of the catalytic subunit. Eukaryot Cell. 2004, 3: 190-199. 10.1128/EC.3.1.190-199.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- Harcus D, Nantel A, Marcil A, Rigby T, Whiteway M: Transcription profiling of cyclic AMP signaling in Candida albicans. Mol Biol Cell. 2004, 15: 4490-4499. 10.1091/mbc.E04-02-0144.PubMed CentralView ArticlePubMedGoogle Scholar
- Hall RA, Mühlschlegel FA: A multi-protein complex controls cAMP signalling and filamentation in the fungal pathogen Candida albicans. Mol Microbiol. 2010, 75: 534-537.View ArticlePubMedGoogle Scholar
- Stoldt VR, Sonneborn A, Leuker C, Ernst JF: Efg1, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 1997, 16: 1982-1991. 10.1093/emboj/16.8.1982.PubMed CentralView ArticlePubMedGoogle Scholar
- Bockmühl DP, Ernst JF: A potential phosphorylation site for an A-type kinase in the Efg1 regulator protein contributes to hyphal morphogenesis of Candida albicans. Genetics. 2001, 157: 1523-1530.PubMed CentralPubMedGoogle Scholar
- Doedt T, Krishnamurthy S, Bockmühl DP, Tebarth B, Stempel C, Russell CL, Brown AJ, Ernst JF: APSES proteins regulate morphogenesis and metabolism in Candida albicans. Mol Biol Cell. 2004, 15: 3167-3180. 10.1091/mbc.E03-11-0782.PubMed CentralView ArticlePubMedGoogle Scholar
- Noffz CS, Liedschulte V, Lengeler K, Ernst JF: Functional mapping of the Candida albicans Efg1 regulator. Eukaryot Cell. 2008, 7: 881-893. 10.1128/EC.00033-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Znaidi S, Nesseir A, Chauvel M, Rossignol T, D’Enfert C: A Comprehensive functional portrait of two heat shock factor-type transcriptional regulators involved in Candida albicans morphogenesis and virulence. PLoS Pathog. 2013, 9: e1003519-10.1371/journal.ppat.1003519.PubMed CentralView ArticlePubMedGoogle Scholar
- Lassak T, Schneider E, Bussmann M, Kurtz D, Manak JR, Srikantha T, Soll DR, Ernst JF: Target specificity of the Candida albicans Efg1 regulator. Mol Microbiol. 2011, 82: 602-618. 10.1111/j.1365-2958.2011.07837.x.View ArticlePubMedGoogle Scholar
- Griffioen G, Anghileri P, Imre E, Baroni MD, Ruis H: Nutritional control of nucleocytoplasmic localization of cAMP-dependent protein kinase catalytic and regulatory subunits in Saccharomyces cerevisiae. J Biol Chem. 2000, 275: 1449-1456. 10.1074/jbc.275.2.1449.View ArticlePubMedGoogle Scholar
- Matsuo Y, McInnis B, Marcus S: Regulation of the subcellular localization of cyclic AMP-dependent protein kinase in response to physiological stresses and sexual differentiation in the fission yeast Schizosaccharomyces pombe. Eukaryot Cell. 2008, 7: 1450-1459. 10.1128/EC.00168-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Beene DL, Scott JD: A-kinase anchoring proteins take shape. Curr Opin Cell Biol. 2007, 19: 192-198. 10.1016/j.ceb.2007.02.011.PubMed CentralView ArticlePubMedGoogle Scholar
- Sastri M, Barraclough DM, Carmichael PT, Taylor SS: A-kinase-interacting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci USA. 2005, 102: 349-354. 10.1073/pnas.0408608102.PubMed CentralView ArticlePubMedGoogle Scholar
- Ernst JF, Bockmühl DP: Gene expression and genetic techniques. Candida and Candidiasis. Edited by: Calderone R. 2001, Washington: ASM Press, 267-278.Google Scholar
- Pokholok DK, Zeitlinger J, Hannett NM, Reynolds DB, Young RA: Activated signal transduction kinases frequently occupy target genes. Science. 2006, 313: 533-536. 10.1126/science.1127677.View ArticlePubMedGoogle Scholar
- Cook KE, O´Shea EK: Hog1 controls global reallocation of RNA PolII upon osmotic shock in Saccharomyces cerevisiae. G3 (Bethesda). 2012, 2: 1129-1136. 2012.View ArticleGoogle Scholar
- Nadal-Ribelles M, Conde N, Flores O, González-Vallinas J, Eyras E, Orozco M, De Nadal E, Posas F: Hog1 bypasses stress-mediated down-regulation of transcription by RNA polymerase II redistribution and chromatin remodeling. Genome Biol. 2012, 3: R106-View ArticleGoogle Scholar
- Pascual-Ahuir A, Proft M: The Sch9 kinase is a chromatin-associated transcriptional activator of osmostress-responsive genes. EMBO J. 2007, 26: 3098-3108. 10.1038/sj.emboj.7601756.PubMed CentralView ArticlePubMedGoogle Scholar
- Zheng X, Wang Y, Wang Y: Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 2004, 23: 1845-1856. 10.1038/sj.emboj.7600195.PubMed CentralView ArticlePubMedGoogle Scholar
- Arnaud MB, Costanzo MC, Skrzypek MS, Binkley G, Lane C, Miyasato SR, Sherlock G: The Candida Genome Database (CGD), a community resource for Candida albicans gene and protein information. Nucleic Acids Res. 2005, 33: D358-D363. 10.1093/nar/gki485. http://www.candidagenome.org/,PubMed CentralView ArticlePubMedGoogle Scholar
- Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD: A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 2012, 148: 126-138. 10.1016/j.cell.2011.10.048.PubMed CentralView ArticlePubMedGoogle Scholar
- Lu Y, Su C, Mao X, Raniga PP, Liu H, Chen J: Efg1-mediated recruitment of NuA4 to promoters is required for hypha-specific Swi/Snf binding and activation in Candida albicans. Mol Biol Cell. 2008, 19: 4260-4272. 10.1091/mbc.E08-02-0173.PubMed CentralView ArticlePubMedGoogle Scholar
- Hnisz D, Bardet AF, Nobile CJ, Petryshyn A, Glaser W, Schöck U, Stark A, Kuchler K: A histone deacetylase adjusts transcription kinetics at coding sequences during Candida albicans morphogenesis. PLoS Genet. 2012, 8: e1003118-10.1371/journal.pgen.1003118.PubMed CentralView ArticlePubMedGoogle Scholar
- Nantel A, Dignard D, Bachewich C, Harcus D, Marcil A, Bouin AP, Sensen CW, Hogues H, Van het Hoog M, Gordon P, Rigby T, Benoit F, Tessier DC, Thomas DY, Whiteway M: Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol Biol Cell. 2002, 13: 3452-65. 10.1091/mbc.E02-05-0272.PubMed CentralView ArticlePubMedGoogle Scholar
- Tebarth B, Doedt T, Krishnamurthy S, Weide M, Monterola F, Dominguez A, Ernst JF: Adaptation of the Efg1p morphogenetic pathway in Candida albicans by negative autoregulation and PKA-dependent repression of the EFG1 gene. J Mol Biol. 2003, 329: 949-962. 10.1016/S0022-2836(03)00505-9.View ArticlePubMedGoogle Scholar
- Román E, Cottier F, Ernst JF, Pla J: Msb2 signaling mucin controls activation of Cek1 mitogen-activated protein kinase in Candida albicans. Eukaryot Cell. 2009, 8: 1235-1249. 10.1128/EC.00081-09.PubMed CentralView ArticlePubMedGoogle Scholar
- Szafranski-Schneider E, Swidergall M, Cottier F, Tielker D, Román E, Pla J, Ernst JF: Msb2 shedding protects Candida albicans against antimicrobial peptides. PLoS Pathog. 2012, 8: e1002501-10.1371/journal.ppat.1002501.PubMed CentralView ArticlePubMedGoogle Scholar
- Bennett RJ, Johnson AD: The role of nutrient regulation and the Gpa2 protein in the mating pheromone response of C. albicans. Mol Microbiol. 2006, 62: 100-119. 10.1111/j.1365-2958.2006.05367.x.View ArticlePubMedGoogle Scholar
- Tuch BB, Mitrovich QM, Homann OR, Hernday AD, Monighetti CK, De La Vega FM, Johnson AD: The transcriptomes of two heritable cell types illuminate the circuit governing their differentiation. PLoS Genet. 2010, 6: e1001070-10.1371/journal.pgen.1001070.PubMed CentralView ArticlePubMedGoogle Scholar
- Birse CE, Irwin MY, Fonzi WA, Sypherd PS: Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect Immun. 1993, 61: 3648-3655.PubMed CentralPubMedGoogle Scholar
- Bailey DA, Feldmann PJ, Bovey M, Gow NA, Brown AJ: The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J Bacteriol. 1996, 178: 5353-53560.PubMed CentralPubMedGoogle Scholar
- Van Helden J, Rios AF, Collado-Vides J: Discovering regulatory elements in non-coding sequences by analysis of spaced dyads. Nucleic Acids Res. 2000, 28: 1808-1818. 10.1093/nar/28.8.1808.View ArticlePubMedGoogle Scholar
- Thomas-Chollier M, Herrmann C, Defrance M, Sand O, Thieffry D, Van Helden J: RSAT peak-motifs: motif analysis in full-size ChIP-seq datasets. Nucleic Acids Res. 2012, 40: e31-10.1093/nar/gkr1104.PubMed CentralView ArticlePubMedGoogle Scholar
- Newcomb LL, Hall DD, Heideman W: AZF1 is a glucose-dependent positive regulator of CLN3 transcription in Saccharomyces cerevisiae. Mol Cell Biol. 2002, 22: 1607-1614. 10.1128/MCB.22.5.1607-1614.2002.PubMed CentralView ArticlePubMedGoogle Scholar
- Hudson DA, Sciascia QL, Sanders RJ, Norris GE, Edwards PJ, Sullivan PA, Farley PC: Identification of the dialysable serum inducer of germ-tube formation in Candida albicans. Microbiology. 2004, 150: 3041-3049. 10.1099/mic.0.27121-0.View ArticlePubMedGoogle Scholar
- Novoa EM, Ribas de Pouplana L: Speeding with control: codon usage, tRNAs, and ribosomes. Trends Genet. 2012, 28: 574-581. 10.1016/j.tig.2012.07.006.View ArticlePubMedGoogle Scholar
- Prill SK, Klinkert B, Timpel C, Gale CA, Schröppel K, Ernst JF: PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance. Mol Microbiol. 2005, 55: 546-560.View ArticlePubMedGoogle Scholar
- Fonzi WA, Irwin MY: Isogenic strain construction and gene mapping in Candida albicans. Genetics. 1993, 134: 717-728.PubMed CentralPubMedGoogle Scholar
- Codon Usage Calculator. http://geneinfinity.org/sms/sms_codonusage.htm,
Copyright
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.






